| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracellular Signaling Peptides and Proteins | 35 | 2015 | 2873 | 3.140 |
Why?
|
| Cysteine Endopeptidases | 14 | 2015 | 548 | 1.980 |
Why?
|
| Liver Regeneration | 6 | 2024 | 213 | 1.970 |
Why?
|
| NF-kappa B | 34 | 2015 | 2488 | 1.710 |
Why?
|
| Endothelium, Vascular | 36 | 2013 | 4433 | 1.610 |
Why?
|
| Nuclear Proteins | 29 | 2014 | 5791 | 1.550 |
Why?
|
| Proteins | 24 | 2006 | 6029 | 1.410 |
Why?
|
| DNA-Binding Proteins | 31 | 2014 | 9585 | 1.330 |
Why?
|
| Muscle, Smooth, Vascular | 13 | 2015 | 1485 | 1.290 |
Why?
|
| Arteriosclerosis | 5 | 2016 | 1064 | 1.190 |
Why?
|
| Hepatectomy | 5 | 2024 | 559 | 1.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 39 | 2016 | 4357 | 1.010 |
Why?
|
| Apoptosis | 27 | 2015 | 9501 | 0.970 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 10 | 2013 | 1407 | 0.880 |
Why?
|
| Aorta | 10 | 2016 | 2039 | 0.830 |
Why?
|
| Models, Animal | 5 | 2024 | 2117 | 0.770 |
Why?
|
| Graft Rejection | 22 | 2015 | 4426 | 0.610 |
Why?
|
| Liver | 7 | 2024 | 7509 | 0.590 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2012 | 382 | 0.570 |
Why?
|
| I-kappa B Proteins | 6 | 2005 | 212 | 0.550 |
Why?
|
| Transfection | 19 | 2010 | 5781 | 0.540 |
Why?
|
| Transplantation, Heterologous | 16 | 1999 | 2379 | 0.530 |
Why?
|
| Interferon-gamma | 15 | 2021 | 3157 | 0.520 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 9 | 1991 | 899 | 0.520 |
Why?
|
| Islets of Langerhans | 5 | 2003 | 1345 | 0.500 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 329 | 0.480 |
Why?
|
| Inflammation | 12 | 2015 | 10756 | 0.460 |
Why?
|
| Interferon-beta | 2 | 2014 | 345 | 0.440 |
Why?
|
| Animals | 94 | 2024 | 167963 | 0.430 |
Why?
|
| Transplantation, Homologous | 12 | 2016 | 4810 | 0.430 |
Why?
|
| Zinc Fingers | 5 | 2005 | 568 | 0.430 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1306 | 0.410 |
Why?
|
| Interleukin-6 | 6 | 2016 | 3215 | 0.410 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 173 | 0.410 |
Why?
|
| Mice, Inbred BALB C | 13 | 2016 | 6216 | 0.400 |
Why?
|
| Tunica Intima | 3 | 2016 | 459 | 0.400 |
Why?
|
| Dermis | 1 | 2013 | 202 | 0.390 |
Why?
|
| Liver Failure | 2 | 2005 | 249 | 0.390 |
Why?
|
| Adenoviridae | 12 | 2015 | 1084 | 0.380 |
Why?
|
| Cytokines | 18 | 2014 | 7343 | 0.370 |
Why?
|
| Cells, Cultured | 26 | 2015 | 18957 | 0.370 |
Why?
|
| Hyperplasia | 6 | 2024 | 1155 | 0.370 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 267 | 0.360 |
Why?
|
| Graft Survival | 10 | 2006 | 3794 | 0.340 |
Why?
|
| Lymphocyte Activation | 12 | 1996 | 5496 | 0.340 |
Why?
|
| Cell Proliferation | 10 | 2024 | 10446 | 0.330 |
Why?
|
| Hepatocytes | 7 | 2015 | 1229 | 0.330 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 877 | 0.320 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 1991 | 2536 | 0.320 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2014 | 1796 | 0.310 |
Why?
|
| PPAR alpha | 1 | 2009 | 174 | 0.310 |
Why?
|
| Atherosclerosis | 3 | 2014 | 3517 | 0.310 |
Why?
|
| Mice | 38 | 2024 | 81208 | 0.310 |
Why?
|
| Endothelial Cells | 6 | 2020 | 3539 | 0.290 |
Why?
|
| Gene Expression Regulation | 12 | 2014 | 11903 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 24 | 2004 | 9185 | 0.290 |
Why?
|
| Cattle | 9 | 2013 | 3847 | 0.280 |
Why?
|
| Cytoprotection | 6 | 2014 | 200 | 0.280 |
Why?
|
| Ubiquitin | 2 | 2015 | 838 | 0.280 |
Why?
|
| Receptors, Tumor Necrosis Factor | 4 | 2002 | 585 | 0.280 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2015 | 358 | 0.270 |
Why?
|
| Lipid Metabolism | 2 | 2015 | 1902 | 0.270 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2010 | 1112 | 0.270 |
Why?
|
| U937 Cells | 3 | 2014 | 262 | 0.260 |
Why?
|
| Complement System Proteins | 6 | 2020 | 782 | 0.250 |
Why?
|
| Minor Histocompatibility Antigens | 5 | 2013 | 293 | 0.250 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 1436 | 0.240 |
Why?
|
| E-Selectin | 6 | 1998 | 576 | 0.240 |
Why?
|
| RNA, Small Interfering | 7 | 2024 | 3442 | 0.230 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2002 | 167 | 0.230 |
Why?
|
| Immunity, Innate | 3 | 2015 | 3047 | 0.230 |
Why?
|
| Gene Transfer Techniques | 3 | 2024 | 1204 | 0.220 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2016 | 686 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 1889 | 0.220 |
Why?
|
| Swine | 15 | 2006 | 5899 | 0.220 |
Why?
|
| T-Lymphocytes | 13 | 1997 | 10181 | 0.210 |
Why?
|
| Carotid Arteries | 3 | 2015 | 951 | 0.210 |
Why?
|
| Reperfusion Injury | 1 | 2009 | 1023 | 0.210 |
Why?
|
| Up-Regulation | 7 | 2015 | 4122 | 0.210 |
Why?
|
| Interleukin-1 | 7 | 1999 | 1249 | 0.210 |
Why?
|
| Protein Biosynthesis | 4 | 2003 | 2105 | 0.200 |
Why?
|
| Homeodomain Proteins | 3 | 2001 | 2414 | 0.200 |
Why?
|
| Autoimmune Diseases | 2 | 2014 | 2250 | 0.200 |
Why?
|
| Gelatin | 1 | 2024 | 221 | 0.200 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2001 | 1854 | 0.200 |
Why?
|
| Signal Transduction | 12 | 2024 | 23376 | 0.200 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2004 | 739 | 0.190 |
Why?
|
| CD40 Ligand | 1 | 2003 | 521 | 0.190 |
Why?
|
| Kidney Transplantation | 10 | 2005 | 4215 | 0.190 |
Why?
|
| Renal Artery | 1 | 2003 | 370 | 0.180 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2013 | 1126 | 0.180 |
Why?
|
| Monocytes | 5 | 2010 | 2575 | 0.180 |
Why?
|
| Repressor Proteins | 3 | 2001 | 2981 | 0.180 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2024 | 560 | 0.180 |
Why?
|
| Neural Stem Cells | 2 | 2020 | 884 | 0.180 |
Why?
|
| Vascular System Injuries | 1 | 2024 | 247 | 0.180 |
Why?
|
| Proto-Oncogenes | 1 | 2001 | 320 | 0.170 |
Why?
|
| Gene Expression | 9 | 2009 | 7588 | 0.170 |
Why?
|
| Energy Metabolism | 2 | 2011 | 2869 | 0.170 |
Why?
|
| Liver Transplantation | 2 | 2009 | 2325 | 0.170 |
Why?
|
| Lipopolysaccharides | 5 | 2014 | 2209 | 0.170 |
Why?
|
| bcl-X Protein | 4 | 2003 | 413 | 0.170 |
Why?
|
| Protein Engineering | 1 | 2003 | 541 | 0.170 |
Why?
|
| Nitric Oxide | 4 | 2010 | 2141 | 0.170 |
Why?
|
| Luciferases | 3 | 2013 | 716 | 0.170 |
Why?
|
| Microbubbles | 1 | 2020 | 128 | 0.160 |
Why?
|
| Diffusion of Innovation | 1 | 2024 | 730 | 0.160 |
Why?
|
| Rats | 19 | 2024 | 23711 | 0.160 |
Why?
|
| Interferons | 2 | 2020 | 705 | 0.160 |
Why?
|
| Epithelial Cells | 2 | 2012 | 3663 | 0.150 |
Why?
|
| Macrophages | 2 | 2010 | 5745 | 0.150 |
Why?
|
| Caspase 8 | 3 | 2009 | 189 | 0.150 |
Why?
|
| Killer Cells, Natural | 3 | 2004 | 2203 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2014 | 15789 | 0.150 |
Why?
|
| Vasculitis | 2 | 2001 | 523 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 22023 | 0.140 |
Why?
|
| Galactosamine | 2 | 2009 | 27 | 0.140 |
Why?
|
| Recombinant Proteins | 7 | 2003 | 6538 | 0.140 |
Why?
|
| Antigens, CD | 4 | 1997 | 4000 | 0.140 |
Why?
|
| Forecasting | 2 | 2024 | 2932 | 0.140 |
Why?
|
| Humans | 82 | 2024 | 760621 | 0.130 |
Why?
|
| Thiocarbamates | 1 | 1995 | 30 | 0.130 |
Why?
|
| Genetic Vectors | 8 | 2010 | 3380 | 0.130 |
Why?
|
| Phosphorylation | 5 | 2014 | 8313 | 0.130 |
Why?
|
| Cell Movement | 4 | 2014 | 5206 | 0.130 |
Why?
|
| Cyclin A | 1 | 2015 | 60 | 0.130 |
Why?
|
| Mice, Knockout | 5 | 2015 | 14372 | 0.130 |
Why?
|
| Adenoviruses, Human | 1 | 1997 | 255 | 0.120 |
Why?
|
| Endothelium | 1 | 1997 | 764 | 0.120 |
Why?
|
| Cyclin E | 1 | 2015 | 155 | 0.120 |
Why?
|
| Polyvinyl Alcohol | 1 | 2015 | 73 | 0.120 |
Why?
|
| Mice, Inbred CBA | 2 | 1993 | 436 | 0.120 |
Why?
|
| Hydrogen Peroxide | 3 | 2009 | 732 | 0.120 |
Why?
|
| RNA, Messenger | 9 | 2015 | 12766 | 0.120 |
Why?
|
| Electrochemical Techniques | 1 | 2015 | 95 | 0.120 |
Why?
|
| Necrosis | 3 | 2009 | 1612 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 2895 | 0.120 |
Why?
|
| Cytotoxins | 1 | 2015 | 153 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15697 | 0.110 |
Why?
|
| Enzyme Activation | 4 | 2010 | 3602 | 0.110 |
Why?
|
| Mice, Inbred DBA | 2 | 1991 | 622 | 0.110 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 1019 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2020 | 8158 | 0.110 |
Why?
|
| Interleukin-3 | 2 | 1991 | 425 | 0.110 |
Why?
|
| Pyrrolidines | 1 | 1995 | 340 | 0.110 |
Why?
|
| Cyclin D1 | 1 | 2015 | 451 | 0.110 |
Why?
|
| STAT1 Transcription Factor | 1 | 2014 | 333 | 0.110 |
Why?
|
| Fas-Associated Death Domain Protein | 2 | 2004 | 27 | 0.110 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2380 | 0.110 |
Why?
|
| Antilymphocyte Serum | 2 | 1998 | 482 | 0.100 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4625 | 0.100 |
Why?
|
| Gene Silencing | 2 | 2010 | 1513 | 0.100 |
Why?
|
| Heme Oxygenase-1 | 3 | 2014 | 364 | 0.100 |
Why?
|
| Replication Protein C | 3 | 2001 | 25 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2015 | 5039 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 3707 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4573 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17790 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 475 | 0.100 |
Why?
|
| Cycloheximide | 2 | 2004 | 343 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 18137 | 0.100 |
Why?
|
| Muromonab-CD3 | 7 | 1993 | 104 | 0.100 |
Why?
|
| Cerebral Ventricles | 1 | 2014 | 542 | 0.100 |
Why?
|
| Caspases | 3 | 2004 | 878 | 0.100 |
Why?
|
| Heart Transplantation | 5 | 1999 | 3224 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 3 | 1995 | 1602 | 0.090 |
Why?
|
| Transcription, Genetic | 4 | 2011 | 7593 | 0.090 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 1098 | 0.090 |
Why?
|
| Encephalitis | 1 | 2014 | 437 | 0.090 |
Why?
|
| Cell Division | 2 | 2009 | 4463 | 0.090 |
Why?
|
| Down-Regulation | 3 | 2021 | 2913 | 0.090 |
Why?
|
| Microcirculation | 2 | 2013 | 1278 | 0.090 |
Why?
|
| Transcriptional Activation | 3 | 2003 | 1755 | 0.090 |
Why?
|
| Veins | 2 | 2012 | 765 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2011 | 12103 | 0.090 |
Why?
|
| Viruses | 1 | 2014 | 376 | 0.090 |
Why?
|
| Neointima | 1 | 2010 | 134 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3604 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 704 | 0.080 |
Why?
|
| Chemokine CCL2 | 2 | 2005 | 605 | 0.080 |
Why?
|
| Oxidants | 1 | 2009 | 169 | 0.080 |
Why?
|
| Saphenous Vein | 2 | 2010 | 537 | 0.080 |
Why?
|
| Organ Transplantation | 1 | 1999 | 1150 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 114 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2471 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4490 | 0.080 |
Why?
|
| Genomics | 1 | 2024 | 5794 | 0.080 |
Why?
|
| Liver Failure, Acute | 1 | 2009 | 181 | 0.070 |
Why?
|
| Glycosylation | 1 | 2010 | 1096 | 0.070 |
Why?
|
| Antioxidants | 1 | 1995 | 1667 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 2138 | 0.070 |
Why?
|
| Dogs | 3 | 2024 | 3841 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 1336 | 0.070 |
Why?
|
| Blood Vessels | 2 | 2006 | 1112 | 0.070 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2006 | 260 | 0.070 |
Why?
|
| Binding Sites | 2 | 2011 | 6048 | 0.070 |
Why?
|
| Tissue Donors | 1 | 1996 | 2313 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 2448 | 0.070 |
Why?
|
| Vasodilation | 1 | 2010 | 962 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3800 | 0.070 |
Why?
|
| Interleukin-8 | 3 | 1998 | 698 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 1997 | 257 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 3 | 1991 | 1869 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2012 | 2864 | 0.060 |
Why?
|
| Caspase 3 | 2 | 2004 | 731 | 0.060 |
Why?
|
| Cricetinae | 4 | 1999 | 2427 | 0.060 |
Why?
|
| Mice, Nude | 1 | 1991 | 3607 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2014 | 1302 | 0.060 |
Why?
|
| Membrane Proteins | 4 | 2014 | 7850 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2005 | 3105 | 0.060 |
Why?
|
| Caspase 6 | 1 | 2004 | 15 | 0.060 |
Why?
|
| Plasmids | 3 | 2001 | 2275 | 0.060 |
Why?
|
| Nephritis | 1 | 2005 | 149 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2010 | 1411 | 0.060 |
Why?
|
| Valine | 1 | 2006 | 409 | 0.060 |
Why?
|
| Transcription Factor RelA | 3 | 2002 | 251 | 0.060 |
Why?
|
| Rats, Inbred Strains | 4 | 2003 | 2094 | 0.060 |
Why?
|
| Body Temperature | 3 | 1991 | 777 | 0.060 |
Why?
|
| Acute Disease | 2 | 2014 | 7269 | 0.060 |
Why?
|
| Coronary Vessels | 3 | 2010 | 3112 | 0.060 |
Why?
|
| Mice, Inbred A | 1 | 2003 | 246 | 0.060 |
Why?
|
| Lymphocyte Depletion | 2 | 2004 | 602 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2009 | 778 | 0.050 |
Why?
|
| Thrombospondins | 1 | 2024 | 193 | 0.050 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 435 | 0.050 |
Why?
|
| Cell Line | 5 | 2020 | 15620 | 0.050 |
Why?
|
| Brain Chemistry | 6 | 1984 | 959 | 0.050 |
Why?
|
| Genes, bcl-2 | 1 | 2003 | 119 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 1997 | 1529 | 0.050 |
Why?
|
| Motor Activity | 5 | 1991 | 2687 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 2414 | 0.050 |
Why?
|
| Cadherins | 1 | 2007 | 898 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2010 | 3484 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2006 | 11071 | 0.050 |
Why?
|
| Protective Agents | 1 | 2003 | 150 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 1741 | 0.050 |
Why?
|
| Genetic Engineering | 3 | 1997 | 933 | 0.050 |
Why?
|
| DNA Primers | 1 | 2006 | 2819 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2011 | 5785 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2002 | 514 | 0.050 |
Why?
|
| Coculture Techniques | 3 | 2020 | 1342 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8651 | 0.050 |
Why?
|
| Thromboplastin | 1 | 2003 | 286 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2007 | 2934 | 0.050 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2020 | 56 | 0.050 |
Why?
|
| Carbon Monoxide | 1 | 2004 | 540 | 0.050 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2024 | 377 | 0.050 |
Why?
|
| Genes | 2 | 1999 | 1845 | 0.040 |
Why?
|
| Fas Ligand Protein | 1 | 2001 | 215 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 2 | 2002 | 908 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2013 | 1860 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2014 | 9287 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2006 | 905 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2004 | 3455 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 9411 | 0.040 |
Why?
|
| Interleukin-2 | 6 | 1992 | 1889 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2002 | 412 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 2640 | 0.040 |
Why?
|
| Ubiquitination | 2 | 2015 | 1008 | 0.040 |
Why?
|
| Lactates | 2 | 1981 | 404 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2001 | 6068 | 0.040 |
Why?
|
| Genes, Dominant | 3 | 1998 | 863 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 65017 | 0.040 |
Why?
|
| Agranulocytosis | 1 | 1979 | 99 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2001 | 381 | 0.040 |
Why?
|
| Syndrome | 4 | 1993 | 3280 | 0.040 |
Why?
|
| Lymphotoxin-alpha | 1 | 1998 | 94 | 0.040 |
Why?
|
| Sucrose | 2 | 1991 | 156 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5253 | 0.040 |
Why?
|
| Kidney | 2 | 2005 | 7064 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 1999 | 140 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 524 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2003 | 1818 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9530 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2004 | 1435 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2006 | 1182 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1999 | 869 | 0.040 |
Why?
|
| Male | 19 | 2024 | 359744 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2020 | 4938 | 0.040 |
Why?
|
| Immunogenetics | 1 | 1997 | 66 | 0.040 |
Why?
|
| Cell Communication | 2 | 2002 | 1653 | 0.040 |
Why?
|
| Complement Inactivator Proteins | 1 | 1997 | 77 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2013 | 3790 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2005 | 3446 | 0.030 |
Why?
|
| Granulocytes | 1 | 1979 | 551 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 621 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13262 | 0.030 |
Why?
|
| Pyridazines | 4 | 1984 | 200 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2020 | 719 | 0.030 |
Why?
|
| Trioses | 1 | 1976 | 3 | 0.030 |
Why?
|
| Antibodies | 3 | 2007 | 2421 | 0.030 |
Why?
|
| Diphosphoglyceric Acids | 1 | 1976 | 31 | 0.030 |
Why?
|
| Dihydroxyacetone | 1 | 1976 | 8 | 0.030 |
Why?
|
| Ischemia | 1 | 2005 | 1893 | 0.030 |
Why?
|
| Regeneration | 1 | 2005 | 1506 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2008 | 319 | 0.030 |
Why?
|
| Brain | 5 | 2020 | 26951 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1997 | 278 | 0.030 |
Why?
|
| Genes, jun | 1 | 1995 | 68 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1997 | 818 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1995 | 78 | 0.030 |
Why?
|
| Calcium | 1 | 2009 | 5725 | 0.030 |
Why?
|
| Biological Transport | 1 | 2020 | 2086 | 0.030 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2002 | 608 | 0.030 |
Why?
|
| Genes, Bacterial | 2 | 1991 | 1071 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2985 | 0.030 |
Why?
|
| Th2 Cells | 2 | 1997 | 1047 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 1674 | 0.030 |
Why?
|
| Diffuse Axonal Injury | 1 | 2014 | 49 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6131 | 0.030 |
Why?
|
| Receptors, Vasopressin | 1 | 2014 | 106 | 0.030 |
Why?
|
| Thioredoxins | 1 | 1995 | 201 | 0.030 |
Why?
|
| Diarrhea | 2 | 1991 | 1319 | 0.030 |
Why?
|
| Histocompatibility | 1 | 2015 | 316 | 0.030 |
Why?
|
| Monitoring, Immunologic | 2 | 1990 | 98 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2002 | 1380 | 0.030 |
Why?
|
| Genome, Viral | 1 | 1997 | 658 | 0.030 |
Why?
|
| Laparotomy | 2 | 1973 | 465 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20080 | 0.030 |
Why?
|
| Leukemia | 1 | 1981 | 1520 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 550 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2005 | 10182 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 1996 | 805 | 0.030 |
Why?
|
| Prosencephalon | 1 | 2014 | 305 | 0.030 |
Why?
|
| Skin | 1 | 2006 | 4466 | 0.030 |
Why?
|
| Shock, Hemorrhagic | 2 | 1984 | 223 | 0.030 |
Why?
|
| Histamine Release | 1 | 1991 | 136 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1979 | 1328 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 788 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 1993 | 915 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 376 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1993 | 562 | 0.020 |
Why?
|
| Species Specificity | 2 | 1995 | 2418 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4353 | 0.020 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2010 | 5 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1993 | 630 | 0.020 |
Why?
|
| Biogenic Amines | 4 | 1984 | 53 | 0.020 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 1991 | 23 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1991 | 886 | 0.020 |
Why?
|
| Mitochondria | 1 | 2004 | 3600 | 0.020 |
Why?
|
| Air Pressure | 1 | 2010 | 74 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 1993 | 532 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1991 | 1763 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1994 | 3804 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1993 | 616 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1993 | 691 | 0.020 |
Why?
|
| Biopsy | 2 | 1993 | 6771 | 0.020 |
Why?
|
| RNA Interference | 2 | 2010 | 2846 | 0.020 |
Why?
|
| Corticosterone | 1 | 1990 | 304 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 290 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 211 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 828 | 0.020 |
Why?
|
| Insulin | 2 | 2003 | 6597 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2014 | 918 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2009 | 80 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2672 | 0.020 |
Why?
|
| Receptors, Purinergic | 1 | 2009 | 66 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2221 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 237 | 0.020 |
Why?
|
| Interferon Type I | 2 | 1990 | 559 | 0.020 |
Why?
|
| Child, Institutionalized | 1 | 1969 | 106 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2009 | 173 | 0.020 |
Why?
|
| Lymphatic System | 1 | 1990 | 254 | 0.020 |
Why?
|
| Hypothermia | 1 | 1990 | 188 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 10827 | 0.020 |
Why?
|
| Spleen | 1 | 1994 | 2298 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1991 | 407 | 0.020 |
Why?
|
| Time Factors | 5 | 2008 | 40165 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 296 | 0.020 |
Why?
|
| Neoplasms | 2 | 2014 | 22072 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15757 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1997 | 1394 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 897 | 0.020 |
Why?
|
| Hodgkin Disease | 2 | 1973 | 1378 | 0.020 |
Why?
|
| Salmonella | 1 | 1987 | 126 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1991 | 4219 | 0.020 |
Why?
|
| Models, Biological | 3 | 1997 | 9467 | 0.020 |
Why?
|
| Polysomnography | 1 | 2013 | 1825 | 0.020 |
Why?
|
| Astrocytes | 1 | 2014 | 1338 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1976 | 2415 | 0.020 |
Why?
|
| Nucleotides | 1 | 2009 | 450 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 978 | 0.020 |
Why?
|
| Cell Survival | 2 | 2009 | 5797 | 0.020 |
Why?
|
| Interleukins | 1 | 1990 | 785 | 0.020 |
Why?
|
| Placebos | 1 | 1969 | 1668 | 0.020 |
Why?
|
| Antibodies, Heterophile | 2 | 1995 | 128 | 0.020 |
Why?
|
| Propidium | 1 | 2004 | 42 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2004 | 103 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2005 | 256 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2004 | 185 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2005 | 516 | 0.010 |
Why?
|
| Reperfusion | 1 | 2005 | 271 | 0.010 |
Why?
|
| Adult | 9 | 2013 | 219994 | 0.010 |
Why?
|
| Fever | 1 | 1991 | 1617 | 0.010 |
Why?
|
| Female | 9 | 2024 | 391270 | 0.010 |
Why?
|
| Primates | 2 | 1997 | 523 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 435 | 0.010 |
Why?
|
| Adolescent | 5 | 2002 | 87810 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 197 | 0.010 |
Why?
|
| Lysosomes | 1 | 2009 | 920 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 983 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1991 | 1190 | 0.010 |
Why?
|
| Catecholamines | 1 | 1984 | 385 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 736 | 0.010 |
Why?
|
| Middle Aged | 7 | 2013 | 220352 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2005 | 617 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1987 | 1387 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2007 | 835 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 1490 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 2006 | 4899 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 1982 | 116 | 0.010 |
Why?
|
| Piracetam | 1 | 1982 | 88 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2002 | 42063 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 397 | 0.010 |
Why?
|
| Electrophoresis | 1 | 2002 | 234 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1987 | 4169 | 0.010 |
Why?
|
| Th1 Cells | 2 | 1997 | 1032 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 12293 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2004 | 822 | 0.010 |
Why?
|
| Central Nervous System Stimulants | 1 | 1969 | 1174 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1630 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 822 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1981 | 394 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2475 | 0.010 |
Why?
|
| Cadmium Poisoning | 1 | 1980 | 11 | 0.010 |
Why?
|
| Thrombosis | 1 | 1994 | 3052 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 2061 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 1992 | 3025 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2004 | 1837 | 0.010 |
Why?
|
| Lymphocytes | 2 | 2002 | 2611 | 0.010 |
Why?
|
| Marine Toxins | 1 | 1979 | 24 | 0.010 |
Why?
|
| Serotonin | 1 | 1984 | 1040 | 0.010 |
Why?
|
| Aged | 4 | 2013 | 169152 | 0.010 |
Why?
|
| Cell Death | 1 | 2004 | 1672 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1996 | 11481 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4925 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 16939 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1982 | 663 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2006 | 4035 | 0.010 |
Why?
|
| Child | 3 | 2002 | 79806 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2005 | 1612 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1989 | 2093 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1991 | 4166 | 0.010 |
Why?
|
| Blood Pressure | 3 | 1984 | 8525 | 0.010 |
Why?
|
| Metabolism | 1 | 1979 | 193 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 1928 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 1484 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 2002 | 810 | 0.010 |
Why?
|
| Pancreas | 1 | 2004 | 1677 | 0.010 |
Why?
|
| Phenotype | 3 | 2008 | 16546 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1997 | 252 | 0.010 |
Why?
|
| Rabbits | 3 | 1981 | 4773 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 2 | 2005 | 2471 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1998 | 594 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 13630 | 0.010 |
Why?
|
| Nervous System | 1 | 1979 | 543 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22053 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1997 | 1154 | 0.010 |
Why?
|
| Transgenes | 1 | 1998 | 1006 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2802 | 0.010 |
Why?
|
| Directed Molecular Evolution | 1 | 1996 | 158 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2002 | 1927 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2002 | 1398 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 2722 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 1493 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1997 | 554 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 3106 | 0.010 |
Why?
|
| Life Expectancy | 1 | 1981 | 1248 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1998 | 1955 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5870 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3726 | 0.010 |
Why?
|
| Complement Activation | 1 | 1995 | 446 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1998 | 995 | 0.010 |
Why?
|
| Blood Gas Analysis | 2 | 1984 | 379 | 0.010 |
Why?
|
| Prednisone | 1 | 1997 | 1565 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36290 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 4407 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2002 | 2145 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1997 | 1400 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 25942 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 12427 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8482 | 0.010 |
Why?
|
| Platelet Activation | 1 | 1995 | 660 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 1973 | 286 | 0.010 |
Why?
|
| Splenectomy | 1 | 1973 | 391 | 0.010 |
Why?
|
| Porins | 1 | 1991 | 79 | 0.010 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 1970 | 28 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 418 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1981 | 6498 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1997 | 3094 | 0.010 |
Why?
|
| Blood Glucose | 2 | 1984 | 6381 | 0.010 |
Why?
|
| Meningitis | 1 | 1991 | 218 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1997 | 1827 | 0.010 |
Why?
|
| Body Weight | 1 | 1981 | 4611 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 3735 | 0.010 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1991 | 227 | 0.010 |
Why?
|
| Colony-Stimulating Factors | 1 | 1990 | 218 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 1991 | 224 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1055 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 866 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1998 | 3682 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1990 | 356 | 0.010 |
Why?
|
| Nephritis, Hereditary | 1 | 1989 | 78 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15289 | 0.000 |
Why?
|
| Blood Coagulation | 1 | 1995 | 1157 | 0.000 |
Why?
|
| Antidepressive Agents | 1 | 1981 | 2890 | 0.000 |
Why?
|
| Cadaver | 1 | 1992 | 1345 | 0.000 |
Why?
|
| Amniotic Fluid | 1 | 1970 | 378 | 0.000 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1989 | 133 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15840 | 0.000 |
Why?
|
| Growth Substances | 1 | 1990 | 768 | 0.000 |
Why?
|
| Morpholines | 2 | 1981 | 583 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 553 | 0.000 |
Why?
|
| Open Reading Frames | 1 | 1991 | 814 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 58741 | 0.000 |
Why?
|
| Operon | 1 | 1987 | 370 | 0.000 |
Why?
|
| Hypertension | 2 | 1989 | 8594 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 1304 | 0.000 |
Why?
|
| Prospective Studies | 2 | 2006 | 54303 | 0.000 |
Why?
|
| Hypotension | 1 | 1991 | 883 | 0.000 |
Why?
|
| Prognosis | 2 | 1989 | 29658 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2006 | 24123 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 39261 | 0.000 |
Why?
|
| Interprofessional Relations | 1 | 1969 | 989 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1991 | 3969 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1984 | 900 | 0.000 |
Why?
|
| Electroshock | 1 | 1981 | 121 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 58995 | 0.000 |
Why?
|
| Ascorbic Acid | 1 | 1984 | 655 | 0.000 |
Why?
|
| Omentum | 1 | 1961 | 169 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1979 | 7408 | 0.000 |
Why?
|
| Base Sequence | 1 | 1991 | 12446 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1992 | 8555 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1991 | 13451 | 0.000 |
Why?
|
| Adenosine | 1 | 1984 | 834 | 0.000 |
Why?
|
| Infant | 1 | 1981 | 36060 | 0.000 |
Why?
|
| Patient Care Team | 1 | 1969 | 2511 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1991 | 17624 | 0.000 |
Why?
|
| Stomach Neoplasms | 1 | 1948 | 1423 | 0.000 |
Why?
|
| Intestinal Obstruction | 1 | 1961 | 434 | 0.000 |
Why?
|
| Dopamine | 1 | 1984 | 1595 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1981 | 1428 | 0.000 |
Why?
|
| Disease | 1 | 1961 | 671 | 0.000 |
Why?
|
| Sex Factors | 1 | 1989 | 10547 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1969 | 8056 | 0.000 |
Why?
|
| Hepatomegaly | 1 | 1973 | 84 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2002 | 80372 | 0.000 |
Why?
|
| Splenic Neoplasms | 1 | 1973 | 95 | 0.000 |
Why?
|
| Splenomegaly | 1 | 1973 | 189 | 0.000 |
Why?
|
| Lymphography | 1 | 1973 | 188 | 0.000 |
Why?
|
| Glucose | 1 | 1984 | 4351 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1991 | 26181 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1973 | 1628 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1979 | 6189 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1973 | 4319 | 0.000 |
Why?
|